Overview

Effects of Administration of Fostamatinib on Blood Concentrations of Warfarin in Healthy Subjects

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether fostamatinib influences the plasma concentration of warfarin and changes its blood thinning effect, and to investigate how safe and tolerable it is when administered with warfarin.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Warfarin